These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23183843)

  • 1. Chipping away: improving primary medication adherence.
    Fischer MA
    JAMA Intern Med; 2013 Jan; 173(1):44-5. PubMed ID: 23183843
    [No Abstract]   [Full Text] [Related]  

  • 2. Automated outreach to increase primary adherence to cholesterol-lowering medications.
    Derose SF; Green K; Marrett E; Tunceli K; Cheetham TC; Chiu VY; Harrison TN; Reynolds K; Vansomphone SS; Scott RD
    JAMA Intern Med; 2013 Jan; 173(1):38-43. PubMed ID: 23403978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 4. Needed: pragmatic clinical trials for statin-intolerant patients.
    Maningat P; Breslow JL
    N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
    [No Abstract]   [Full Text] [Related]  

  • 5. Additional insights on how best to utilize statins.
    Feeman WE
    J Fam Pract; 2014 Mar; 63(3):128. PubMed ID: 24701605
    [No Abstract]   [Full Text] [Related]  

  • 6. Niacin: old habits die hard.
    Haynes R; Rahimi K
    Heart; 2016 Feb; 102(3):170-1. PubMed ID: 26769376
    [No Abstract]   [Full Text] [Related]  

  • 7. Dementia and statins.
    Ebrahim S; Shlomo YB; Smith GD; Whincup P; Emberson J
    Lancet; 2001 Mar; 357(9259):882. PubMed ID: 11265976
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin therapy: when to think twice.
    Wahawisan J; Tovar JM; Granberry MC
    J Fam Pract; 2013 Dec; 62(12):726-32. PubMed ID: 24340334
    [No Abstract]   [Full Text] [Related]  

  • 9. Bezafibrate and simvastatin: different beneficial effects for different therapeutic aims.
    Tenenbaum A; Fisman EZ; Motro M
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1978; author reply 1978-9. PubMed ID: 15070976
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid-lowering drugs.
    Med Lett Drugs Ther; 2016 Oct; 58(1506):133-140. PubMed ID: 27755510
    [No Abstract]   [Full Text] [Related]  

  • 11. [In process].
    Reisdorf S
    Med Monatsschr Pharm; 2017 Jun; 40(6):271-3. PubMed ID: 29979855
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM; Gaziano TA
    JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract]   [Full Text] [Related]  

  • 13. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].
    Yiğiner O; Ozmen N; Ozçelik F; Inanç T; Kardeşoğlu E; Uz O; Işılak Z; Aparcı M; Sahin I; Arslan E; Cebeci BS
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus statement on the management of dyslipidemia in Indian subjects: Our perspective.
    Bansal M; Sarat Chandra K; Nair T; Iyengar SS; Gupta R; Manchanda SC; Mohanan PP; Dayasagar Rao V; Manjunath CN; Sawhney JP; Sinha N; Pancholia AK; Mishra S; Kasliwal RR; Kumar S; Krishnan U; Kalra S; Misra A; Shrivastava U; Gulati S
    Indian Heart J; 2016; 68(2):238-41. PubMed ID: 27133351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 17. [How to create cooperative patient for antihypertensive and hypolipidemic therapy].
    Piťha J
    Vnitr Lek; 2017; 63(4):272-276. PubMed ID: 28520451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 19. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 20. Ask the doctors. I have a high cholesterol level and my doctor started me on a statin. He has doubled the dose twice, but my levels are still high. What options do I have?
    Heart Advis; 2003 Mar; 6(3):8. PubMed ID: 12703458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.